The First Lady, Senator Oluremi Tinubu has expressed worry over the high prevalence of cervical cancer in Nigeria.
Speaking at the National launch of the introduction of the HPV Vaccine into the routine immunization schedule of the National Immunization Programe in Abuja today, October 24, the First Lady said that the initiative does not end with the introduction of the vaccine into the routine immunization schedule but that there must be focus on education and awareness about the virus.
She said that regular screenings must be encouraged and there must be improved access to healthcare with behavioral interventions as well.
“For me, I will recommend that girls who are under 18 years of age and sexually active, avail themselves the opportunity of this vaccine, to avoid a future of ill-health and possibly, death.
“In conclusion, I want to emphasize that the introduction of HPV vaccine into our routine immunization schedule is a significant step forward in our mission to protect the health and future of our nations womenfolk and it will lead to a structured and systematic way of achieving a cervical cancer free generation.”
Senator Oluremi Tinubu said that the initiative goes beyond preventing cervical cancer but also demonstrating the commitment of the administration of the President Bola Tinubu’s administration to gender equity and empowering women to take control of their health.
Earlier, the Coordinating Minister for Health and Social Welfare, Professor Mohammed Ali Pate emphasized that the vaccine is safe, effective and already in use in several countries of the world.
“No father or mother who really understand they can prevent a serious disease will stop their daughters from taking the vaccine, except they really do not understand.”
In their goodwill messages, the Sultan of Sokoto, health sector partners and others said that the introduction of the vaccine will go a long way to enhance the health of the female folk in the country.
The First Lady supervised the administration of the vaccine on the girls who were present at the event